Novo Nordisk Inc recalls NovoLog (Insulin aspart) Injection, 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx Only, Ma
Recalled April 21, 2021 · FDA recall D-0616-2021 · Novo Nordisk
Hazard
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors. · FDA Class I
Units
N/A
Sold at
Nationwide in the USA
Description
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Product
NovoLog (Insulin aspart) Injection, 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark NDC 0169-7501-90
Manufacturer(s)
Novo Nordisk Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →